Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Menopausal Med ; 29(3): 127-133, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38230596

RESUMO

OBJECTIVES: To determine the factors affecting the decline in ovarian reserve following laparoscopic ovarian cystectomy (LOC) in women with ovarian endometriosis. METHODS: This retrospective study included 22 women, aged 25-45 years, with regular menstrual cycles who underwent unilateral LOC and were diagnosed with ovarian endometriosis at a university hospital. Blood samples were collected preoperatively and on the third postoperative day to determine the serum anti-Müllerian hormone (AMH) levels for assessment of the decline in ovarian reserve during the early postoperative period. RESULTS: The preoperative hemoglobin level, white blood cell count, and AMH level were associated with changes in the AMH level after unilateral LOC. Among these parameters, only the preoperative hemoglobin level was correlated with the rate of decline in postoperative AMH levels. The preoperative serum AMH level was correlated with the amount of postoperative AMH change but not with its rate of decline. CONCLUSIONS: Preoperative hemoglobin levels may be associated with the rate of decline in AMH levels in the early postoperative period after unilateral LOC.

2.
Bioorg Med Chem ; 12(13): 3543-52, 2004 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-15186838

RESUMO

We describe the solution-phase combinatorial synthesis and pharmacological effect of fifty N,N(')-substituted-N"-1-(4-chlorobenzhydryl)piperazine iminodiacetic acid triamide derivatives as nonpeptide B2 antagonists. The synthesized compounds were tested for their antibradykinin activity by utilizing guinea-pig ileum smooth muscle. Most of the compounds showed antagonistic effects on bradykinin induced contraction. N-acetyl-N(')-(4-methylbenzyl)-N"-1-(4-chlorobenzhydryl)piperazine iminodiacetic acid triamide (A3B1C1) showed the 46% inhibition at 100nM.


Assuntos
Antagonistas dos Receptores da Bradicinina , Técnicas de Química Combinatória , Desenho de Fármacos , Iminoácidos/química , Iminoácidos/farmacologia , Aminação , Animais , Cobaias , Íleo/efeitos dos fármacos , Iminoácidos/síntese química , Masculino , Estrutura Molecular , Músculo Liso/efeitos dos fármacos , Quinolinas/química , Receptores da Bradicinina/química , Receptores da Bradicinina/metabolismo , Soluções/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...